Eculizumab long-term therapy for pediatric renal transplant in aHUS with CFH/CFHR1 hybrid gene

Renal Transplantation Under Prophylactic Eculizumab in Atypical Hemolytic Uremic Syndrome With CFH/CFHR1 Hybrid Protein

(2012) S. Krid et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Eculizumab for Atypical Hemolytic Uremic Syndrome Recurrence in Renal Transplantation

(2012) J. Zuber et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Complement dysregulation and disease: From genes and proteins to diagnostics and drugs

(2012) Santiago Rodriguez de Cordoba et al.   IMMUNOBIOLOGY

Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies

(2012) Julien Zuber et al.   Nature Reviews Nephrology

Pre-emptive Eculizumab and Plasmapheresis for Renal Transplant in Atypical Hemolytic Uremic Syndrome

(2011) C. Nester et al.   Clinical Journal of the American Society of Nephrology

Complement factor H variants I890 and L1007 while commonly associated with atypical hemolytic uremic syndrome are polymorphisms with no functional significance

(2011) Agustín Tortajada et al.   KIDNEY INTERNATIONAL

New insights into postrenal transplant hemolytic uremic syndrome

(2010) Julien Zuber et al.   Nature Reviews Nephrology

Safety and Long-Term Efficacy of Eculizumab in a Renal Transplant Patient with Recurrent Atypical Hemolytic-Uremic Syndrome

(2009)   AMERICAN JOURNAL OF TRANSPLANTATION

Eculizumab for Congenital Atypical Hemolytic–Uremic Syndrome

(2009) Ralph A. Gruppo et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Complement Factor H R1210C Mutation Is Associated With Atypical Hemolytic Uremic Syndrome

(2008) R. Martinez-Barricarte et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY